The effect of losartan on angiotensin II-induced cell proliferation in a rat aorta smooth muscle cell line

The effect of losartan on angiotensin II-induced cell proliferation in a rat aorta smooth muscle cell line

The success of revascularization procedures is limited by recurrent stenosis, which is a narrowing of a blood vessels that results from neo-intimal hyperplasia. The renin-angiotensin-aldosterone system has been implicated in the pathogenesis of neo-intimal hyperplasia, and a role for angiotensin II...

Full description

Bibliographic Details
Main Authors:	Natália Tambelline, Karen Oliveira, Luiz Renato Olchanheski Junior, Regina Sordi, Michel Fleith Otuki, Giovani Marino Favero, Daniel Fernandes
Format:	Article
Language:	English
Published:	Instituto de Tecnologia do Paraná (Tecpar) 2012-04-01
Series:	Brazilian Archives of Biology and Technology
Subjects:	Angiotensin II Losartan Cell proliferation
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132012000200012

Similar Items

Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II/AGTR1 Signaling in Glioblastoma Cells
by: Salvatore Panza, et al.
Published: (2021-09-01)

The effect of angiotensin 1-7 and losartan on renal ischemic/reperfusion injury in male rats
by: Tahereh Safari, et al.
Published: (2019-01-01)

Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan
by: Antônio Carlos Avanza Jr, et al.
Published: (2000-02-01)

Renin angiotensin system blockage by losartan neutralize hypercholesterolemia-induced inflammatory and oxidative injuries
by: Abdulaziz M.S. AlSaad, et al.
Published: (2020-01-01)

Determining the Effects of Morphine, Heroin, and Losartan and the Interaction of each on Losartan in Water Homeostasis Mechanisms by the Kidney in Adult Male Rabbits
by: F Foroohi, et al.
Published: (2015-04-01)

Unveiling Angiotensin II and Losartan-Induced Gene Regulatory Networks Using Human Urine-Derived Podocytes
by: Chantelle Thimm, et al.
Published: (2023-06-01)

The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
by: Galina Anatol'evna Baryshnikova, et al.
Published: (2009-03-01)

Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan
by: Ol'ga Konstantinovna Vikulova, et al.
Published: (2009-09-01)

Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT
by: Patrick G Kehoe, et al.
Published: (2021-11-01)

A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19
by: Michael A. Puskarich, et al.
Published: (2021-07-01)

A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients
by: Gustavo Castaño, et al.
Published: (2003-01-01)

Determination of Losartan and Losartan Carboxylic acid in Human Plasma by New HPLC Method with Fluorescence Detection for Pharmacokinetics Studies
by: Ahmed Abbas Hussein
Published: (2014-12-01)

Anti-stress activity in a polytropic spectrum of pharmacological action of losartan
by: A. O. Syrovay
Published: (2013-02-01)

Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan
by: Francis Essien, et al.
Published: (2021-08-01)

The Effect of Losartan (AT1 Receptor Inhibitor) on Reactive Nitrogen Species and Renal Function after Renal Ischemia-reperfusion in Rat
by: Saeide Baarforoush, et al.
Published: (2016-04-01)

Efficacy and safety of losartan in childhood immunoglobulin A nephropathy: a prospective multicenter study
by: Hyesun Hyun, et al.
Published: (2023-12-01)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
by: Tenenbaum Alexander, et al.
Published: (2002-04-01)

Losartan and magnesium sulfate administration reduce gentamicin-induced nephrotoxicity in rat model
by: Fatemeh Kourkinejad Gharaei, et al.
Published: (2019-04-01)

Angiotensin II type 1 receptor gene polymorphism could influence renoprotective response to losartan treatment in type 1 diabetic patients with high urinary albumin excretion rate
by: Dragović Tamara, et al.
Published: (2010-01-01)

Losartan Alleviates the Side Effects and Maintains the Anticancer Activity of Axitinib
by: Ying Fu, et al.
Published: (2022-04-01)

Pleiotropic Effects of Losartan in Hypertensive Patients with Dyslipidemia
by: Sivakumar Sivasubramaniam, et al.
Published: (2017-09-01)

An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19
by: Charles D. Bengtson, et al.
Published: (2021-02-01)

Renin-angiotensin-system increases phosphorylated tau and Reactive Oxygen Species in human cortical neuron cell line
by: Luz De Dios, et al.
Published: (2022-12-01)

Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats
by: Baracho N.C.V., et al.
Published: (1998-01-01)

Interaction of Sex Hormones and the Renin–Angiotensin System in Ovariectomized Rats Subjected to Ischemia-Reperfusion Induction
by: Halimeh Lakzaei, et al.
Published: (2019-01-01)

Losartan for Preventing Aortic Root Dilatation in Patients with Marfan Syndrome: A Meta-Analysis of Randomized Trials
by: Ayman Elbadawi, et al.
Published: (2019-10-01)

Angiotensin II during experimentally simulated central hypovolemia
by: Theo Walther Jensen, et al.
Published: (2016-03-01)

Combined effects of angiotensin receptor blocker use and physical training in hypertensive men
by: Tábata de Paula Facioli, et al.
Published: (2022-05-01)

Heat Shock Protein 70 and CHIP Promote Nox4 Ubiquitination and Degradation within the Losartan Antioxidative Effect in Proximal Tubule Cells
by: Andrea F. Gil Lorenzo, et al.
Published: (2015-07-01)

Effects of angiotensin II receptor antagonists on anxiety and some oxidative stress markers in rat
by: Ciobica Alin, et al.
Published: (2011-06-01)

Losartan and QT Dispersion in Hypertensive Patients on Maintenance Hemodialysis
by: Alparslan Ersoy, et al.
Published: (2014-12-01)

Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model
by: Wende Li, et al.
Published: (2021-03-01)

Optimized and Validated RP-UPLC Method for the Determination of Losartan Potassium and Chlorthalidone in Pharmaceutical Formulations
by: Tadiboyina Sirisha, et al.
Published: (2015-03-01)

Losartan inhibits hyposmotic-induced increase of IKs current and shortening of action potential duration in guinea pig atrial myocytes
by: Jie Gao, et al.
Published: (2019-12-01)

A randomised clinical trial study assessing the efficacy of 5% losartan potassium loaded in ethosomal gel to treat human keloids: a trial protocol
by: Yuni Eka Anggraini, et al.
Published: (2024-01-01)

An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancerCentral MessagePerspective
by: Hexiao Tang, MD, PhD, et al.
Published: (2024-04-01)

EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Drug-Induced Liver Injury Due To Losartan
by: Joana Diogo, et al.
Published: (2021-11-01)

The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats [version 3; peer review: 1 approved, 2 approved with reservations]
by: Rangga Adhazi Ksatriapraja, et al.
Published: (2024-02-01)

The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats [version 2; peer review: 1 approved, 2 approved with reservations]
by: Rangga Adhazi Ksatriapraja, et al.
Published: (2023-05-01)